Clinical Trials Logo

Acquired Hypomelanosis clinical trials

View clinical trials related to Acquired Hypomelanosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT04419350 Completed - Clinical trials for Acquired Hypomelanosis

Microneedling for Acquired Hypomelanosis

Start date: September 15, 2019
Phase: N/A
Study type: Interventional

Acquired hypomelanosis is a type of cutaneous melanocytopenic hypomelanosis, denoting the lightening of the skin due to a reduction in the number of epidermal and/or follicular melanocytes secondary to physical agents,post-inflammatory, and iatrogenic (steroids). Derma roller is the basic device of microneedling , performs superficial, controlled puncturing of the skin by rolling with miniature fine needles and used as a collagen induction therapy and a transdermal delivery system for therapeutic drugs and vaccines. This minute trauma to the skin that activates regenerative mechanisms and wound healing by releasing growth factors. The release of cytokines and deposition of hemosiderin from dermal bleeding induce the activation of melanocyte and stimulate skin pigmentation plus transdermal traveling of melanocyte